Novartis AG Profile

USD 1.08  1.44%

Novartis AG Summary

Novartis AG (NVS) is traded on New York Stock Exchange in USA. It is located in SWITZERLAND and employs 124,000 people. Novartis AG is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mega-Cap' category with total capitalization of 189.86 B. Novartis AG runs under Healthcare sector within Pharmaceutical Products industry. This company has 2.34 B outstanding shares of which 1.24 M shares are now shorted by investors with about 0.64 days to cover shorted positions. NOVARTIS AG ADS has about 6.39 B in cash with (335.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.74.
Check Novartis AG Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 73.98HorizonTargetOdds Above 73.98
4.64%30 days 73.98 95.12%
Based on normal probability distribution, the odds of Novartis AG to move above current price in 30 days from now is over 95.12% (This Novartis AG probability density function shows the probability of Novartis AG Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Dodge CoxCommon Shares44.3 M3.6 B
Primecap Management CoCommon Shares21.8 M1.8 B
View Novartis AG Diagnostics

Selected Novartis AG Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Novartis AG Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Novartis AG are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Novartis AG researches, develops, manufactures, and markets a range of healthcare products worldwide. Novartis AG was founded in 1895 and is headquartered in Basel, Switzerland. Novartis AG operates under Drug Manufacturers - Major classification in USA and traded on New York Stock Exchange. It employs 124000 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameNovartis AG
CEOPaul HudsonView All
Thematic Classifications
Active Investing Ideas
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressLichtstrasse 35
Foreign Associate  Argentina
ExchangeNew York Stock Exchange
IndustryPharmaceutical Products
Contact Number41 61 324 1111
Related EntityNVSEF
CurrencyUSD - US Dollar


Novartis AG Analyst Recommendations
Target PriceAdvice# of Analysts
Novartis AG current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Novartis AG Analyst Advice  


Novartis AG Earnings Estimates
EPSEstimate Date
Quarterly Estimate1.15April 20, 2017
Novartis AG normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  


Novartis AG Corporate Directors
Ton Buechner Non-Executive Independent Director, MBA
Dimitri Azar Member of the Board of Directors, MBA
Frans Houten Non-Executive Independent Director
Please see also Stocks Correlation. Please also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.